Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 11Other 1Endocrine 1

Conditions

Obesity 45Mucositis 29Neoplasms 23Sexual Dysfunction, Physiological 19Head and Neck Neoplasms 16Breast Neoplasms 16Opioid-Induced Constipation 12Dyspnea 11Constipation 11Pain 10Polycystic Ovary Syndrome 9Weight Loss 7Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Motor Activity 7Diabetes Mellitus 7Cardiovascular Diseases 6Xerostomia 5Stomatitis 5Radiation Injuries 5Overweight 5Sedentary Behavior 4Endometrial Neoplasms 4Diabetes Mellitus, Type 2 4Colorectal Neoplasms 4Bronchiolitis Obliterans Syndrome 4Sexuality 3Salivary Gland Neoplasms 3Hypertension 3Fatty Liver 3

Interventions

Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Erectile Dysfunction × Other × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡